Nicola Klein to Vaccines, Acellular
This is a "connection" page, showing publications Nicola Klein has written about Vaccines, Acellular.
Connection Strength
0.380
-
Licensed pertussis vaccines in the United States. History and current state. Hum Vaccin Immunother. 2014; 10(9):2684-90.
Score: 0.124
-
Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.
Score: 0.107
-
Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008 Mar; 121(3):463-9.
Score: 0.078
-
Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases. J Immunol. 2020 08 15; 205(4):877-882.
Score: 0.046
-
Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: a randomized, controlled, open-label, multicenter study. Vaccine. 2012 May 14; 30(23):3360-8.
Score: 0.026